BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24854664)

  • 1. Predictors of sustained arteriovenous access use for haemodialysis.
    Stoumpos S; Stevens KK; Aitken E; Kingsmore DB; Clancy MJ; Fox JG; Geddes CC
    Am J Nephrol; 2014; 39(6):491-8. PubMed ID: 24854664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.
    Zhang JC; Al-Jaishi A; Perl J; Garg AX; Moist LM
    Am J Kidney Dis; 2015 Oct; 66(4):646-54. PubMed ID: 25975965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.
    Goel N; Kwon C; Zachariah TP; Broker M; Folkert VW; Bauer C; Melamed ML
    BMC Nephrol; 2017 Jan; 18(1):28. PubMed ID: 28095805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre.
    Graham J; Hiremath S; Magner PO; Knoll GA; Burns KD
    Nephrol Dial Transplant; 2008 Nov; 23(11):3585-91. PubMed ID: 18552397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK Renal Registry 16th annual report: chapter 14 2012 multisite dialysis access audit in England, Northern Ireland and Wales and 2011 PD one year follow-up: national and centre-specific analyses.
    Briggs V; Pitcher D; Shaw C; Fluck R; Wilkie M
    Nephron Clin Pract; 2013; 125(1-4):275-94. PubMed ID: 24662178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.
    Lenz O; Sadhu S; Fornoni A; Asif A
    Semin Dial; 2006; 19(6):543-50. PubMed ID: 17150058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AV fistula creation in paediatric patients: outcome is independent of demographics and fistula type reducing usage of venous catheters.
    Matoussevitch V; Taylan C; Konner K; Gawenda M; Kuhr K; Hoppe B; Brunkwall J
    J Vasc Access; 2015; 16(5):382-7. PubMed ID: 26044895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of arteriovenous fistula creation in patients With CKD: a decision analysis.
    Shechter SM; Skandari MR; Zalunardo N
    Am J Kidney Dis; 2014 Jan; 63(1):95-103. PubMed ID: 23978336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of vascular access creation prior to dialysis: building the case for early referral.
    Weber CL; Djurdjev O; Levin A; Kiaii M
    ASAIO J; 2009; 55(4):355-60. PubMed ID: 19506469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices.
    Hanko J; Romann A; Taylor P; Copland M; Beaulieu M
    Nephrol Dial Transplant; 2012 Nov; 27(11):4205-10. PubMed ID: 22962410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first 365 days on haemodialysis: variation in the haemodialysis access journey and its associated burden.
    Murray E; Eid M; Traynor JP; Stevenson KS; Kasthuri R; Kingsmore DB; Thomson PC
    Nephrol Dial Transplant; 2018 Jul; 33(7):1244-1250. PubMed ID: 29401294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular accesses in haemodialysis: a challenge to be met.
    Antón-Pérez G; Pérez-Borges P; Alonso-Almán F; Vega-Díaz N
    Nefrologia; 2012; 32(1):103-7. PubMed ID: 22294008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting failure of AV "fistula first" policy in the elderly.
    Hod T; Desilva RN; Patibandla BK; Vin Y; Brown RS; Goldfarb-Rumyantzev AS
    Hemodial Int; 2014 Apr; 18(2):507-15. PubMed ID: 24400842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic haemodialysis with PTFE arterio-venous grafts.
    Chia KH; Ong HS; Teoh MK; Lim TT; Tan SG
    Singapore Med J; 1999 Nov; 40(11):685-90. PubMed ID: 10709405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type of vascular access and survival among very elderly hemodialysis patients.
    Praga M; Merello JI; Palomares I; Bayh I; Marcelli D; Aljama P; Luño J
    Nephron Clin Pract; 2013; 124(1-2):47-53. PubMed ID: 24135465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
    Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
    J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis.
    Vachharajani TJ; Moossavi S; Jordan JR; Vachharajani V; Freedman BI; Burkart JM
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1663-7. PubMed ID: 21685023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas.
    Huijbregts HJ; Bots ML; Moll FL; Blankestijn PJ;
    J Vasc Surg; 2007 May; 45(5):962-7. PubMed ID: 17466788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access.
    García-Cantón C; Rufino-Hernández JM; Vega-Díaz N; Pérez-Borges P; Bosch-Benítez-Parodi E; Saavedra P; García-Gómez C; Marrero-Robayna S; Maceira-Cruz B; Rodríguez-Pérez JC; Checa-Andrés MD
    Nefrologia; 2013; 33(5):629-39. PubMed ID: 24089154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.